Report

specialty enzymes market

Specialty Enzymes Market based on Application (Pharmaceutical, Biotechnology R&D, and Diagnostic), Source, Type (Acylases, Hydratases, Humulin, Oxidase, Lyases, Restriction enzymes, Ligases, Polymerases & Nucleases, Lipases, Amylases, Proteases, Dehydrogenases, Glucouronidse, and Others) and Geography –Global Forecast up to 2026

pages Pages: 92
tables Tables: 101
charts Charts: 70
country Regions/Countries: 4 / 10
compaines Companies: 12
enqhours Enquiry Hours: 10
  • Get Free 10% Customization in this Report

COVID - 19

Covid impact updated reports at special price

Specialty enzymes have grown in popularity in recent years due to their potential applications in fields such as biotechnology, pharmaceuticals, and diagnostics. In pharmaceuticals and diagnostics reactions, specialty enzymes serve as biocatalysts to speed up reactions and achieve the expected results. Specialty enzymes are essential in the pharmaceutical industry for drug formulation and delivery. Pharmaceutical drug formulations based on enzymes are used to treat chronic diseases like cancer and AIDS. In the biotechnology industry, specialty enzymes have long been used for research, especially in molecular biology. They're also used in genetic engineering to cut, duplicate, and bind DNA to meet specific requirements. The specialty enzymes needed for diagnostics must be of the highest purity and produced in small quantities, resulting in high costs and limited use of diagnostic enzymes. The Specialty Enzymes Market is assumed to grow at the rate of 7.31% CAGR by 2026.

Research Methodology:

The Specialty Enzymes Market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Specialty Enzymes Market

Specialty Enzymes Market based on Application

  • Pharmaceutical
  • Biotechnology R&D
  • Diagnostic

Specialty Enzymes Market based on Source

  • Microorganisms
  • Plants
  • Animals

Specialty Enzymes Market based on Type

  • Acylases
  • Hydratases
  • Humulin
  • Oxidase
  • Lyases
  • Restriction enzymes
  • Ligases
  • Polymerases & Nucleases
  • Others

Specialty Enzymes Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

As many pharmaceutical and healthcare manufacturing companies adopt the Specialty Enzymes, which include automation and less human interference, it is one reason for the integrated systems having the fastest growth rate in the specialty enzymes market. Moreover, these integrated systems are more beneficial in manufacturing as they minimize production costs, consume less time, and raise the margin.

As per the application segment, the demand for specialty enzymes market is rapidly expanding Because of the increasing use of enzymes in the pharmaceutical industry. In the pharmaceutical industry, specialty enzymes are often used for disease diagnosis, drug manufacturing, or therapy. One factor driving consumer demand is the increasing use of enzymes in therapies for diseases such as cancer, lysosomal storage disorders, cardiovascular diseases, pain and inflammation management, and others.

Based on the type of polymerases & nucleases segment is expected to dominate the market during the estimated period. Polymerases & nucleases are used in specialty applications, like research & biotechnology, diagnostics, pharmaceuticals, and biocatalysts. Polymerases & nucleases have been gathered together as they both work on nucleic acid Ribonucleic acid and deoxyribonucleic acid are two polymers that are widely used in related applications. These enzymes catalyze the synthesis of deoxyribonucleic acid and ribonucleic acid polymers, as well as recombination, replication, repair, and transcription, and are needed for all nucleic acid processing.

In the regional market, North America accounted for the largest market share in the specialty enzymes market. Enzymes are now available for a wide range of applications thanks to technological advances in this area, and this segment is expected to drive the market's growth. Due to novel and superior performing goods as well as global industrialization, this area is projected to be the largest market. The use of enzymes in the pharmaceutical industry in this area is also on the rise. The United States is the leading nation, and the market in this area has matured. These factors are expected to contribute to the development of the North American market.

The growing frequency of digestive disorders like indigestion and inflammation and other disorders like immunodeficiency and pain support the specialty enzyme market's growth. Specialty enzymes enable the quick and efficient release of these problems and deliver a wide range of applications across various specialty enzyme segments.

BASF, DuPont, Roche Holding, Novozymes, DSM, Sanofi, and Codexis.

  • This Specialty Enzymes market report presents the geographical region and sub-segments expected to have the fastest growth and largest share.
  • This report describes the factors driving and restricting the market growth and the challenges and opportunities of the market.
  • This report gives information on the market-leading players and their position in the market.
  • This report also provides continuous market developments and innovations taking place in the Specialty Enzymes market.
  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
      1. Porter Five Forces
    3. Related Markets
  4. Market characteristics
    1. Market Overview
    2. Market Segmentation
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    4. DRO - Impact Analysis
  5. Application: Market Size & Analysis
    1. Overview
    2. Pharmaceutical
    3. Biotechnology R&D
    4. Diagnostic
  6. Source: Market Size & Analysis
    1. Overview
    2. Microorganisms
    3. Plants
    4. Animals
  7. Type: Market Size & Analysis
    1. Overview
    2. Acylases
    3. Hydratases
    4. Humulin
    5. Oxidase
    6. Lyases
    7. Restriction enzymes
    8. Ligases
    9. Polymerases & Nucleases
    10. Others
  8. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  9. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
  10. Vendor Profiles
    1. Amano Enzymes
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    2. Dyadic International
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    3. Specialty Enzymes & Probiotics
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    4. Enzyme Development Corporation
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    5. Nagase & Co. Ltd
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    6. BBI Solutions
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    7. Advanced Enzymes
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    8. Sanofi
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    9. Biocatalysts
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    10. Enzyme Supplies
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
  11. Companies to Watch
    1. Amicogen
      1. Overview
      2. Products & Services
      3. Business Strategy
    2. Antozyme Biotech
      1. Overview
      2. Products & Services
      3. Business Strategy
  12. Analyst Opinion
  13. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

TABLE 1.           GLOBAL SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 2.           GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR PHARMACEUTICAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 3.           GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR BIOTECHNOLOGY R&D, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 4.           GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR DIAGNOSTIC, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 5.           GLOBAL SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 6.           GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR MICROORGANISMS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 7.           GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR PLANTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 8.           GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 9.           GLOBAL SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 10.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR ACYLASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 11.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR HYDRATASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 12.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR HUMULIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 13.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR OXIDASE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 14.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR LYASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 15.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR RESTRICTION ENZYMES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 16.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR LIGASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 17.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR POLYMERASES & NUCLEASES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 18.         GLOBAL SPECIALTY ENZYMES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 19.         NORTH AMERICA SPECIALTY ENZYMES MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 20.         NORTH AMERICA SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 21.         NORTH AMERICA SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 22.         NORTH AMERICA SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 23.         U.S SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 24.         U.S SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 25.         U.S SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 26.         CANADA SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 27.         CANADA SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 28.         CANADA SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 29.         EUROPE SPECIALTY ENZYMES MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 30.         EUROPE SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 31.         EUROPE SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 32.         EUROPE SPECIALTY ENZYMES MARKET VALUE, TYPE, 2020-2026 (USD BILLION)

TABLE 33.         GERMANY SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 34.         GERMANY SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 35.         GERMANY SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 36.         U.K SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 37.         U.K SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 38.         U.K SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 39.         FRANCE SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 40.         FRANCE SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 41.         FRANCE SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 42.         ITALY SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 43.         ITALY SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 44.         ITALY SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 45.         SPAIN SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 46.         SPAIN SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 47.         SPAIN SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 48.         ROE SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 49.         ROE SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 50.         ROE SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 51.         ASIA PACIFIC SPECIALTY ENZYMES MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 52.         ASIA PACIFIC SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 53.         ASIA PACIFIC SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 54.         ASIA PACIFIC SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 55.         CHINA SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 56.         CHINA SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 57.         CHINA SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 58.         INDIA SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 59.         INDIA SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 60.         INDIA SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 61.         JAPAN SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 62.         JAPAN SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 63.         JAPAN SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 64.         REST OF APAC SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 65.         REST OF APAC SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 66.         REST OF APAC SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 67.         REST OF WORLD SPECIALTY ENZYMES MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 68.         REST OF WORLD SPECIALTY ENZYMES MARKET VALUE, BY SOURCE, 2020-2026 (USD BILLION)

TABLE 69.         REST OF WORLD SPECIALTY ENZYMES MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)

TABLE 70.         AMANO ENZYMES: FINANCIALS

TABLE 71.         AMANO ENZYMES: PRODUCTS & SERVICES      

TABLE 72.         AMANO ENZYMES: RECENT DEVELOPMENTS    

TABLE 73.         DYADIC INTERNATIONAL: FINANCIALS

TABLE 74.         DYADIC INTERNATIONAL: PRODUCTS & SERVICES      

TABLE 75.         DYADIC INTERNATIONAL: RECENT DEVELOPMENTS     

TABLE 76.         SPECIALTY ENZYMES & PROBIOTICS: FINANCIALS       

TABLE 77.         SPECIALTY ENZYMES & PROBIOTICS: PRODUCTS & SERVICES 

TABLE 78.         SPECIALTY ENZYMES & PROBIOTICS: RECENT DEVELOPMENTS

TABLE 79.         ENZYME DEVELOPMENT CORPORATION: FINANCIALS  

TABLE 80.         ENZYME DEVELOPMENT CORPORATION: PRODUCTS & SERVICES         

TABLE 81.         ENZYME DEVELOPMENT CORPORATION: RECENT DEVELOPMENTS       

TABLE 82.         NAGASE & CO. LTD: FINANCIALS         

TABLE 83.         NAGASE & CO. LTD: PRODUCTS & SERVICES   

TABLE 84.         NAGASE & CO. LTD: RECENT DEVELOPMENTS  

TABLE 85.         BBI SOLUTIONS: FINANCIALS  

TABLE 86.         BBI SOLUTIONS: PRODUCTS & SERVICES        

TABLE 87.         BBI SOLUTIONS: RECENT DEVELOPMENTS       

TABLE 88.         ADVANCED ENZYMES: FINANCIALS      

TABLE 89.         ADVANCED ENZYMES: PRODUCTS & SERVICES

TABLE 90.         ADVANCED ENZYMES: RECENT DEVELOPMENTS          

TABLE 91.         SANOFI: FINANCIALS   

TABLE 92.         SANOFI: PRODUCTS & SERVICES         

TABLE 93.         SANOFI: RECENT DEVELOPMENTS       

TABLE 94.         BIOCATALYSTS: FINANCIALS   

TABLE 95.         BIOCATALYSTS: PRODUCTS & SERVICES         

TABLE 96.         BIOCATALYSTS: RECENT DEVELOPMENTS        

TABLE 97.         ENZYME SUPPLIES: FINANCIALS          

TABLE 98.         ENZYME SUPPLIES: PRODUCTS & SERVICES    

TABLE 99.         ENZYME SUPPLIES: RECENT DEVELOPMENTS   

TABLE 100.       AMICOGEN: PRODUCTS & SERVICES    

TABLE 101.       ANTOZYME BIOTECH: PRODUCTS & SERVICES 

Research Framework

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting
Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources

Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

outicon

Specialty Enzymes Market based on Application (Pharmaceutical, Biotechnology R&D, and Diagnostic), Source, Type (Acylases, Hydratases, Humulin, Oxidase, Lyases, Restriction enzymes, Ligases, Polymerases & Nucleases, Lipases, Amylases, Proteases, Dehydrogenases, Glucouronidse, and Others) and Geography –Global Forecast up to 2026
Interested in this report?
Get your FREE sample now!
DOWNLOAD NOW

Select User License

$
Request For Sample Report
Enquire Before Buying

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Speak to our analyst
Related Reports
Card image cap
Genital Herpes Treatment Market by Type of Drugs (Acyclovir,...
$ 4000
Card image cap
Compounding Pharmacy Market by Therapeutic Areas (Hormone Re...
$ 4000
Card image cap
Attention Deficit Hyperactivity Market by Drug Type (Stimula...
$ 4000
Card image cap
Heparin Sales Market By Type (Low Molecular Weight Heparin, ...
$ 4000
Card image cap
Vaccine Market By Technology Type (Recombinant, Conjugate Va...
$ 4000
Card image cap
Yeast Infection Market based on Pathogen Type (Candida albic...
$ 4000